Orforglipron
Also known as: LY3502970
The first oral non-peptide GLP-1 receptor agonist. A daily pill achieving near-injectable weight loss results without needles.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
~25–50 hours
36–45 mg daily
Oral
Mechanism of Action
Small molecule that survives stomach acid and activates GLP-1 receptors orally, eliminating the need for injection-based delivery.
Key Research Areas
Frequently Asked Questions
What is Orforglipron?▾
How does Orforglipron work?▾
What is the recommended dosage for Orforglipron?▾
What is the half-life of Orforglipron?▾
Is Orforglipron FDA approved?▾
Ready to get started with Orforglipron?
Order from our COA-verified partner — free US shipping, pharmaceutical-grade quality.
Research Disclaimer
The information provided about Orforglipron is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.